Kamla Kant Shukla | Cancer Genetics | Best Researcher Award

Prof Dr. Kamla Kant Shukla | Cancer Genetics | Best Researcher Award

All India Institute of Medical Sciences, Jodhpur India

Author Profile

Early Academic Pursuits:

Dr. Kamla Kant Shukla began his academic journey with a strong foundation in Biochemistry, earning a Ph.D. in Medical Biochemistry from King George’s Medical University, Lucknow, in 2010. His earlier academic achievements include an M.Sc. in Biochemistry from A.P.S. University, Rewa, in 2001.

Professional Endeavors:

His professional journey in academia includes various roles at AIIMS Jodhpur, where he currently serves as an Additional Professor of Biochemistry since July 2023. Prior to this, he held positions as an Associate Professor (July 2020 - June 2023) and Assistant Professor (June 2017 - June 2020) in the Department of Trauma & Emergency. Before joining AIIMS Jodhpur, Dr. Shukla gained valuable experience as a Senior/Junior Resident in the Department of Biochemistry at AIIMS Jodhpur from January 2013 to May 2017. He also pursued a Postdoctoral Fellowship at Chungang University, South Korea, from 2011 to 2012.

Contributions and Research Focus:

His research program is characterized by its focus on two distinct areas. Firstly, he delves into understanding the role of epigenetic and gene regulations in embryonic development and cancers, with a particular emphasis on developing epigenetic biomarkers and novel modalities for treatment. Secondly, he assesses the impact of endocrine disruptive chemicals on the epigenome, exploring genotoxicity, cell signaling pathways, and non-coding RNA in reproductive and cancer biology.

Accolades and Recognition:

His significant contributions have been acknowledged with various accolades and awards. Notably, he was elected as a Member of the National Academy of Medical Sciences (India) in 2022 and received the Shri Om Prakash Sharma Young Scientist Award in 2021 from the Indian Academy of Biomedical Sciences. His international recognition includes being elected as a Member of the American Association for Clinical Chemistry, USA, in 2022, and as an Associate Member of the Royal Society of Biology, United Kingdom, in 2020. Additionally, he received a Travel Award at the 8th Seoul International Congress of Endocrinology and Metabolism (SICEM 2020) in Seoul, South Korea.

Impact and Influence:

His impact extends beyond his academic and research roles. His membership in esteemed national and international scientific societies reflects the recognition of his expertise in the field.

Legacy and Future Contributions:

His legacy is marked by his commitment to advancing knowledge in the fields of epigenetics, genomics, and endocrine disruption. His multifaceted research approach and international collaborations position him as a key figure in biochemistry and medical sciences. His future contributions are anticipated to further enrich our understanding of epigenetic mechanisms and their implications in developmental biology and cancer research.

Citations

A total of  2298 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations            2298
  • h-index              21
  • i10-index           30

Notable Publications